Maravai LifeSciences Holdings, Inc. Contract Liability (Deferred Revenue)
Maravai LifeSciences Holdings, Inc. (MRVI) had Contract Liability (Deferred Revenue) of $1.99 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-02-26
- 2025-12-31: Contract with Customer, Liability, Current $1.99M.
- 2025-09-30: Contract with Customer, Liability, Current $1.73M.
- 2025-06-30: Contract with Customer, Liability, Current $1.64M.
- 2025-03-31: Contract with Customer, Liability, Current $2.76M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2025-12-31 | $1.99M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.64M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $2.76M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.38M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.90M 10-K · filed 2025-03-18 | $1.83M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.15M 10-K · filed 2025-03-18 | $2.08M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.21M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.36M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $2.55M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $2.46M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.05M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.09M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $5.82M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $5.43M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $3.69M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $10.21M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $66.72M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $109.49M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $119.17M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $78.06M 10-K · filed 2022-03-01 |